Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors

Robert Adler, Michael Kozlov, Sara Sash, Manan D. Mehta, Emily Cowen, Katerina Svigos, Jessica Lori Feig

Open source

DOI
10.36849/jdd.9963
Published
2026-10-01
Container
Journal of Drugs in Dermatology
Publisher
SanovaWorks
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.36849/jdd.9963,
  title = {Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors},
  author = {Robert Adler and Michael Kozlov and Sara Sash and Manan D. Mehta and Emily Cowen and Katerina Svigos and Jessica Lori Feig},
  year = {2026},
  journal = {Journal of Drugs in Dermatology},
  doi = {10.36849/jdd.9963},
  url = {https://doi.org/10.36849/jdd.9963}
}

RIS

TY  - JOUR
TI  - Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors
AU  - Robert Adler
AU  - Michael Kozlov
AU  - Sara Sash
AU  - Manan D. Mehta
AU  - Emily Cowen
AU  - Katerina Svigos
AU  - Jessica Lori Feig
PY  - 2026
JO  - Journal of Drugs in Dermatology
DO  - 10.36849/jdd.9963
UR  - https://doi.org/10.36849/jdd.9963
ER  - 

APA

Adler, R., Kozlov, M., Sash, S., Mehta, M. D., Cowen, E., Svigos, K., & Feig, J. L. (2026). Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9963

Source records